US 8815848
Compositions and methods for inhibition of the JAK pathway
granted A61KA61K31/343A61K31/436
Quick answer
US patent 8815848 (Compositions and methods for inhibition of the JAK pathway) held by Rigel Pharmaceuticals, Inc. expires Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Aug 26 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K31/343, A61K31/436, A61K31/505, A61K31/506